Koo Jakap insider trades
Koo Jakap has filed 4 Form 4s with the SEC that we hold, all for Apimeds Pharmaceuticals US, Inc. (APUS), as Director. Across all of them we count 1 purchase worth $56.7K and 0 sales worth $0 reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a purchase of 28,500 shares of Apimeds Pharmaceuticals US, Inc. worth $56.7K, dated 2025-05-12. The first filing on our record is dated 2025-05-14 and the latest 2025-11-13.
Apimeds Pharmaceuticals US, Inc. (APUS)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2025-05-12 | P, purchase reported on Form 4 | 28,500 | $56.7K | 2025-05-14 |
Counted from the Form 4 filings this reporting owner (SEC CIK 2041972) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms